MDxHealth is trading 13.28% up at $0.92 after reporting Q2 revenue of $27.2 million, up 16% year over year.
- Management reaffirmed 2026 revenue guidance of $110–115 million
- A $20 million registered direct financing strengthened the balance sheet
- The August 14 rally preceded the continued August 17 advance